Oncology and Cancer

Kalorama Information’s new comprehensive report, Worldwide Sequencer Market, 2023-2028, provides an in-depth analysis of the sequencing market, highlighting key trends, challenges, strategies, companies, and products. The report includes detailed market share estimates, revenue growth forecasts, and a thorough examination of the competitive landscape, featuring significant deals and products.

The report offers historical data for 2023…

Kalorama Information’s latest report, The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028, is now available for purchase. This comprehensive study delves into the dynamic landscape of LDTs, exploring both the services market and the market for test products sold to clinical laboratories.

The Worldwide Market for Laboratory-Developed Tests includes comprehensive analysis of the effects of…

Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that have taken place from Q1 2021 to Q1 2024, providing valuable insights for companies and…

Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…

Explore the latest trends and forecasts in the point-of-care (POC) diagnostic tests market with Kalorama Information’s The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11^th Edition. Discover the key growth areas and technological advancements shaping the future of POC diagnostics.

Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in…

Explore the latest trends and developments in the in vitro diagnostic (IVD) market with Kalorama Information’s comprehensive report, In Vitro Diagnostic (IVD) Trends and Market Update: March 2024. Gain insights into key growth segments, industry trends, and emerging technologies shaping the future of IVD.

The report offers updated data analysis based on Kalorama Information’s annual…

Liquid biopsies have emerged as a groundbreaking diagnostic tool, offering a minimally invasive method to analyze tumor-derived materials circulating in biological fluids. These biopsies provide invaluable information for cancer diagnosis, treatment, and monitoring, addressing some of the limitations and risks associated with traditional tissue biopsies and imaging techniques.

The liquid biopsy market is undergoing significant…

In recent years, molecular diagnostics has become the fastest-growing segment within the global in vitro diagnostics (IVD) market, significantly influenced by the COVID-19 pandemic. This report examines the current state of the multi-billion-dollar molecular diagnostic market, highlighting key areas of opportunity in infectious diseases, cancer, and transplant diagnostics. North America and Europe continue to lead…

Explore the dynamic world of cell and gene therapy deal-making with Kalorama Information’s comprehensive report, Cell and Gene Therapy Funding and Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2023. This report tracks the deal-making activities in cell and gene therapy since 2021, providing insightful graphs of quarterly trends from 2021-2023 and detailing…

In recent decades, genetic technologies for research and diagnostics have transformed healthcare, offering new possibilities in precision medicine and disease management. Next-generation sequencing (NGS) has revolutionized genetic disease diagnostics and oncology, providing comprehensive insights at a relatively low cost. PCR continues to evolve, remaining a central tool in molecular diagnostics. In situ hybridization techniques (ISH)…

As in vitro diagnostic (IVD) testing returns to its vital role in healthcare, it remains a cornerstone in medical practice, providing crucial insights for physicians, from diagnosis to precision medicine. While COVID-19 testing sees a decline, it continues to influence total revenues for 2023. In this ever-changing landscape, characterized by new products, shifts in global…

The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.

 

Key…